Our (e)Books and (e)Journals
IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.
Browse by Subject
- Administrative Sciences
- Biochemistry, Medicine & Health
- Computer & Communication Sciences
- Environmental Sciences
- Food & Nutrition
- Geographic Information Science
IOS Press publishes books and journals (online and in print) in a broad range of scientific, technical and medical (STM) subject areas. Click on a subject above to see our titles.
NewsKeep me informed
June 2, 2021 - Amsterdam, NL – On the eve of the 50th anniversary of the 1972 Stockholm conference that created the United Nations Environmental Programme, it is clear that the global environmental situation has only deteriorated. In "Our Earth Matters: Pathways to a Better Common Environmental Future" – an extended special issue of Environmental Policy and Law (EPL) – leading scholars from more than five continents call for an honest introspection of what has been attained over the last 50 years relating to regulatory processes and laws and explore future trajectories with new ideas and frameworks for environmental governance in the 21st century.June 2, 2021
Treatabolome Project Designed to Shorten Diagnosis-to-Treatment Time for Patients with Rare Diseases
June 1, 2021 - Amsterdam, NL – The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise. Developed under the Solve-RD European Research Project, it is intended to reduce treatment delays for patients with rare diseases by directly linking diagnosis and treatment information. This initiative is highly relevant to neuromuscular disorders as they are rare diseases by definition. In this special issue of the Journal of Neuromuscular Diseases, experts contribute Treatabolome-feeding systematic literature reviews on rare neurological and neuromuscular disorders.June 1, 2021
May 11, 2021 - Amsterdam, NL – It is projected that up to 152 million people worldwide will be living with Alzheimer’s disease (AD) by 2050. To date there are no drugs that have a substantial positive impact on either the prevention or reversal of cognitive decline. A growing body of evidence finds that targeting lifestyle and vascular risk factors have a beneficial effect on overall cognitive performance. A new review in the new review in the Journal of Alzheimer’s Disease, published by IOS Press, examines research that finds spiritual fitness, a new concept in medicine that centers on psychological and spiritual wellbeing, and Kirtan Kriya, a simple 12-minute meditative practice, may reduce multiple risk factors for AD.May 11, 2021
COVID-19 Lockdown Increases Depression in Patients with Alzheimer’s Disease: Is This Backed by Research?
May 10, 2021 - Nantes, France – The lockdown, as implemented to cope with the COVID-19 pandemic, has drastically changed our everyday lives. Patients with Alzheimer’s disease (AD), especially those who live in retirement homes, are not indifferent to the dramatic impact of the lockdown on social interactions.May 10, 2021